{"id":212325,"name":"TRAVERE THERAPEUTICS","slug":"travere-therapeutics","state":"CA","country":"United States of America","description":"Pharmaceutical company","totalSpending":383500,"filings":20,"yearlySpending":[{"year":2021,"income":40000},{"year":2022,"income":105000},{"year":2023,"income":112500},{"year":2024,"income":62000},{"year":2025,"income":64000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"},{"code":"GOV","display":"Government Issues"},{"code":"EDU","display":"Education"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["THE HEALTH EQUITY STRATEGIES GROUP, LLC"],"lobbyists":["BRITT WEINSTOCK"],"govEntities":["HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Educating congressional offices -- with a focus on minority caucus offices -- about rare kidney disease and a forthcoming legislative measure to address this issue.","Educating congressional offices -- with a focus on minority caucus offices -- about rare kidney disease and a forthcoming legislative measure to address this issue.","Educating congressional offices -- with a focus on minority caucus offices -- about rare kidney disease and a forthcoming legislative measure to address this issue.","Educating congressional offices -- with a focus on minority caucus offices -- about rare kidney disease and a forthcoming legislative measure to address this issue.","Rare kidney disease"]}